Who owns PMV Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PMVP from SEC Form 13F filings across 65 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 65 institutions disclosed 56.5M shares of PMV Pharmaceuticals, Inc. worth $94.4M — about 85.4% of shares outstanding; the largest disclosed holder is BML Capital Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
65
13F holders
$94.4M
value, 2026 filers
85.4%
of shares outstanding (56.5M sh)
9
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PMVP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BML Capital Management, LLC | 7.3M | $12.2M | 6.5% | 11.1% | +37.5% |
| 2 | TANG CAPITAL MANAGEMENT LLC | 7.3M | $12.2M | 0.6% | 11% | +71.6% |
| 3 | SAMSARA BIOCAPITAL, LLCNEW | 7.2M | $12.1M | 1.1% | 10.9% | new |
| 4 | Sio Capital Management, LLC | 3.6M | $6.1M | 1.1% | 5.5% | +38.0% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | $5.1M | 0.0% | 4.7% | +53.3% |
| 6 | ADAR1 Capital Management, LLC | 2.7M | $4.5M | 0.2% | 4.1% | +1243.4% |
| 7 | Euclidean Capital LLC | 2.6M | $4.4M | 1.4% | 4% | 0.0% |
| 8 | TWO SIGMA INVESTMENTS, LP | 2.4M | $4.1M | 0.0% | 3.7% | +24.3% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.4M | $3.9M | 0.0% | 3.6% | 0.0% |
| 10 | ACADIAN ASSET MANAGEMENT LLC | 2.3M | $3.8M | 0.0% | 3.5% | +3.1% |
| 11 | Boxer Capital Management, LLCNEW | 2.0M | $3.4M | 0.3% | 3.1% | new |
| 12 | Eversept Partners, LP | 2.0M | $3.3M | 0.2% | 3% | +3.9% |
| 13 | Affinity Asset Advisors, LLCNEW | 1.8M | $2.9M | 0.1% | 2.6% | new |
| 14 | ArrowMark Colorado Holdings LLC | 1.7M | $2.8M | 0.1% | 2.6% | -13.5% |
| 15 | MILLENNIUM MANAGEMENT LLCNEW | 1.5M | $2.4M | 0.0% | 2.2% | new |
| 16 | BlackRock, Inc. | 916,518 | $1.5M | 0.0% | 1.4% | -0.4% |
| 17 | BIT Capital GmbH | 714,407 | $1.2M | 0.0% | 1.1% | +75.3% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 500,327 | $836,293 | 0.0% | 0.8% | +5.7% |
| 19 | Aldebaran Capital, LLC | 489,540 | $817,532 | 0.6% | 0.7% | +4.7% |
| 20 | Walleye Capital LLC | 487,141 | $813,525 | 0.0% | 0.7% | +45.1% |
| 21 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 427,528 | $713,972 | 0.0% | 0.6% | -0.3% |
| 22 | Assenagon Asset Management S.A. | 328,744 | $549,002 | 0.0% | 0.5% | -0.4% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 301,866 | $504,116 | 0.0% | 0.5% | +18.5% |
| 24 | CITADEL ADVISORS LLC | 268,338 | $448,124 | 0.0% | 0.4% | +467.2% |
| 25 | BANK OF AMERICA CORP /DE/ | 265,898 | $444,050 | 0.0% | 0.4% | +10.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.